• May 15, 2026 pet ct in melanoma clinicians guides to radionucl ances. As research advances, the development of melanoma-specific tracers and hybrid imaging techniques promises to further refine disease detection and guide personalized therapy. For clinicians, staying informed about these innovations and applying best practices will improve patient outcome By Allison Gusikowski
• Jan 2, 2026 melanoma as: Anti-CTLA-4 agents (e.g., ipilimumab) Anti-PD-1 agents (e.g., pembrolizumab, nivolumab) Targeted Therapy: For BRAF-mutant melanomas, BRAF inhibitors (e.g., vemurafenib, dabrafenib) combined with MEK inhibitors (e.g., By Miss Valerie Lubowitz
• Apr 7, 2026 histological diagnosis of nevi and melanoma rregular contours. Nuclear to cytoplasmic ratio: Increased, with prominent nucleoli. Mitotic activity: Increased, including atypical mitoses, especially in the dermal component. Pagetoid spread: Presence of atypical melanocytes above the basal layer, By Erin Stamm
